Metabolic reprogramming in lymphoma, including glucose metabolism, fatty acid synthesis, and glutaminolysis, is a dynamic process driven by the dysregulation of HIF, MYC, p53, PI3K/mTOR, and AMPK signaling pathways, as well as EBV. This evidence concerns the gene TP53 and lymphoma.